Latest Issue

Connecting Drug Delivery174

Issue No #174 June 2025 June 18th, 2025

Issue 174 - Jun 2025

Inside the magazine

INTEGRATING DIGITAL HEALTH SYSTEMS INTO MEDICAL DEVICE ECOSYSTEMS: CONSIDERATIONS & STRATEGIES

EdgeOne Medical

INTEGRATING DIGITAL HEALTH SYSTEMS INTO MEDICAL DEVICE ECOSYSTEMS: CONSIDERATIONS & STRATEGIES

Jerzy Wojcik and Liat Shochat take a look at how digital health technologies are transforming the pharmaceutical and combination product sectors. They consider the challenges in bringing these technologies to market and how the full potential of connected health technologies can be achieved.

NAVIGATING SEMICONDUCTOR LIFECYCLE CHALLENGES IN MEDTECH: A STRATEGIC SHIFT TOWARDS ASICs

NAVIGATING SEMICONDUCTOR LIFECYCLE CHALLENGES IN MEDTECH: A STRATEGIC SHIFT TOWARDS ASICs

Andy Kelly considers the evolution of semiconductor technology and the impact of the release of new and upgraded components. This article discusses how strategic decisions during the early stages of product design can determine the future viability of a medical device and considers the cost savings offered by application-specific integrated circuits through a reduction in the number of components required.

CONNECTED BUT PROTECTED – SECURELY CONNECTING DRUG DELIVERY DEVICES

Dr Joachim Wilke

CONNECTED BUT PROTECTED – SECURELY CONNECTING DRUG DELIVERY DEVICES

Dr Joachim Wilke discusses wireless connectivity in novel drug delivery devices, highlighting the possibilities for improved patient outcomes and care, the associated security risks, as well as examining the wide range of cyber security solutions and standards to mitigate these issues.

SMART ENOUGH: DESIGNING DRUG DELIVERY DEVICES THAT PUT PATIENTS FIRST

SMART ENOUGH: DESIGNING DRUG DELIVERY DEVICES THAT PUT PATIENTS FIRST

Andy Pidgeon challenges the assumption that more advanced technology is always better, re-examining the design approach to connected autoinjectors from the patient perspective and highlighting the value of simplicity and usability – digging into the idea that, by investigating the real-world needs of patients, drug delivery device designers can ensure that their devices are serving those needs, rather than creating unnecessary new challenges for users.

Top